How to Safely Prevent Venous Thromboembolism in Severe Trauma Patients

Int Heart J. 2020 Sep 29;61(5):993-998. doi: 10.1536/ihj.20-153. Epub 2020 Sep 12.

Abstract

Venous thromboembolism (VTE) is a life-threatening complication after trauma. Several studies have reported VTE prophylaxis using low-molecular-weight heparin; however, there is no consensus for prophylaxis after trauma. This study aimed to assess the efficacy and safety of our new anticoagulation therapy protocol using unfractionated heparin (UFH) plus intermittent pneumatic compression (IPC) to prevent post-traumatic VTE in high-risk trauma patients.This study enrolled 70 trauma patients who were admitted to the emergency medical center of Nagasaki University Hospital and had Risk Assessment Profile (RAP) scores ≥ 5. After stopping bleeding at the trauma site, all patients received intravenous UFH (10,000 U/day) plus IPC, which was continued for 14 days or until the patients could walk. On days 7 and 14, all patients underwent lower extremity sonography for deep-vein thrombosis screening. VTE incidences between patients with the above intervention and historical controls with IPC alone were compared.No significant differences in age, sex, and the RAP score were observed between the 105 controls and intervention patients. VTE occurrence was fewer in patients with the intervention (14.3%) than in the controls (28.6%; P = 0.029). No hemorrhagic complications occurred after UFH administration. Multivariable logistic analysis revealed a significant association between the intervention and low incidence of VTE (odds ratio: 0.390; 95% confidence interval: 0.163-0.913; P = 0.030).Routine UFH administration with IPC may prevent post-traumatic VTE without adverse events.

Keywords: Deep-vein thrombosis; Preventable trauma death; Prevention; Pulmonary embolism; Unfractionated heparin.

MeSH terms

  • Aged
  • Anticoagulants / therapeutic use*
  • Cohort Studies
  • Female
  • Fibrin Fibrinogen Degradation Products / metabolism
  • Heparin / therapeutic use*
  • Hospitalization
  • Humans
  • Injury Severity Score
  • Intermittent Pneumatic Compression Devices*
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Partial Thromboplastin Time
  • Pulmonary Embolism / prevention & control*
  • Risk Assessment
  • Thrombophilia / blood
  • Venous Thromboembolism / prevention & control*
  • Venous Thrombosis / prevention & control*
  • Wounds and Injuries / blood
  • Wounds and Injuries / therapy*

Substances

  • Anticoagulants
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Heparin